Publications by authors named "Bruce A Keyt"

Claim this Profile
A
An engineered IgM antibody targeting CD20 has enhanced complement-dependent cytotoxicity compared with an IgG.
Kevin C Hart, Paul R Hinton, Marigold Manlusoc, Kevin B Carlin, Samuel Schneider, Bruce A Keyt

Exp Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.
Zhiqiang Ku, Xuping Xie, Paul R Hinton, Xinli Liu, Xiaohua Ye, Bruce A Keyt

Nature· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGM-7354, an Immunocytokine with IL15 Fused to an Anti-PD-L1 IgM, Induces NK and CD8+ T cell-Mediated Cytotoxicity of PD-L1-Positive Tumor Cells.
Mélanie Desbois, Thierry Giffon, Poonam Yakkundi, Carolyn R Denson, Keerthana Sekar, Bruce A Keyt

Cancer Immunol Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV.
Hailong Guo, Bomsoo Cho, Paul R Hinton, Sijia He, Yongjun Yu, Bruce A Keyt

Emerg Microbes Infect· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies as drugs-a Keystone Symposia report.
Jennifer Cable, Erica Ollmann Saphire, Adrian C Hayday, Timothy D Wiltshire, Jarrod J Mousa, Bruce A Keyt

Ann N Y Acad Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.
William R Strohl, Zhiqiang Ku, Zhiqiang An, Stephen F Carroll, Bruce A Keyt

BioDrugs· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199.
Beatrice T Wang, Tasnim Kothambawala, Ling Wang, Thomas J Matthew, Susan E Calhoun, Bruce A Keyt

Mol Cancer Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.
Zhiqiang Ku, Xuping Xie, Paul R Hinton, Xinli Liu, Xiaohua Ye, Bruce A Keyt

Nature· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure, Function, and Therapeutic Use of IgM Antibodies.
Bruce A Keyt, Ramesh Baliga, Angus M Sinclair, Stephen F Carroll, Marvin S Peterson

Antibodies (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients.
Ellen J Collarini, F Eun-Hyung Lee, Orit Foord, Minha Park, Gizette Sperinde, Bruce A Keyt

J Immunol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody discovery via multiplexed single cell characterization.
William D Harriman, Ellen J Collarini, Gizette V Sperinde, Magnus Strandh, Marjan M Fatholahi, Bruce A Keyt

J Immunol Methods· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.
Tammo Ostendorf, Claudia R C van Roeyen, Jeffrey D Peterson, Uta Kunter, Frank Eitner, Bruce A Keyt

J Am Soc Nephrol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis